Such upregulation was more marked in CD8+ than in CD4+T cells (fold increase of 4, 7 and 2, respectively in CD8+ T cell of PBMC, normal colon and CRC; average values of 3 clinical samples) (Figure S3C). The gene discussed is CD8A; the disease is colorectal carcinoma.